You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

contiguous stage II adult diffuse mixed cell lymphoma

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Contiguous Stage II Small Lymphocytic Lymphoma, Noncontiguous Stage II Small Lymphocytic Lymphoma, Prolymphocytic Leukemia Trial

Active, not recruiting
  • Contiguous Stage II Small Lymphocytic Lymphoma
  • +11 more
  • MOR00208
  • +2 more
  • Columbus, Ohio
    The Ohio State University Comprehensive Cancer Center
Feb 24, 2022

Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Seattle (procedure, drug, biological, radiation)

Recruiting
  • Acute Leukemia
  • +18 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +8 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 26, 2022

Ann Arbor Stage III DLBCL, Ann Arbor Stage IIX (Bulky) DLBCL, Ann Arbor Stage IV DLBCL Trial in United States (drug, other,

Suspended
  • Ann Arbor Stage III Diffuse Large B-Cell Lymphoma
  • +20 more
  • Tucson, Arizona
  • +110 more
Jan 31, 2023

Diffuse Large B-cell Lymphoma (DLBCL) Trial in Worldwide (CTL019)

Completed
  • Diffuse Large B-cell Lymphoma (DLBCL)
  • Tisagenlecleucel
  • Lymphodepleting chemotherapy
  • San Francisco, California
  • +25 more
Jan 27, 2023

Malignant Non-Hodgkin Lymphomas Trial in Berne (CD34+ cell selection)

Active, not recruiting
  • Malignant Non-Hodgkin Lymphomas
  • CD34+ cell selection
  • Berne, Switzerland
    Department for Medical Oncology; University Hospital/Inselspital
Jul 29, 2021

Stage I Mantle Cell Lymphoma, Stage II Contiguous Mantle Cell Lymphoma, Stage II Non-Contiguous Mantle Cell Lymphoma Trial in

Active, not recruiting
Has Results
  • Stage I Mantle Cell Lymphoma
  • +4 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +8 more
  • Buffalo, New York
  • +1 more
Mar 9, 2022

Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Detroit (3'-deoxy-3'-[18F]fluorothymidine)

Recruiting
  • Brain and Central Nervous System Tumors
  • +8 more
  • 3'-deoxy-3'-[18F]fluorothymidine
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Mar 30, 2022

Lymphoma Trial in Worldwide (immunoscintigraphy, technetium Tc 99m epratuzumab)

Unknown status
  • Lymphoma
  • immunoscintigraphy
  • technetium Tc 99m epratuzumab
  • Los Angeles, California
  • +7 more
Aug 12, 2021

Lymphoma Trial in Worldwide (immunoscintigraphy, technetium Tc 99m epratuzumab)

Unknown status
  • Lymphoma
  • immunoscintigraphy
  • technetium Tc 99m epratuzumab
  • Los Angeles, California
  • +7 more
Aug 12, 2021

Acute Biphenotypic Leukemia, Acute Erythroid Leukemia in Remission, Acute Leukemia in Remission Trial in Seattle (drug,

Terminated
Has Results
  • Acute Biphenotypic Leukemia
  • +29 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 4, 2023

Contiguous Stage II Mantle Cell Lymphoma, Noncontiguous Stage II Mantle Cell Lymphoma, Stage I Mantle Cell Lymphoma Trial in

Active, not recruiting
  • Contiguous Stage II Mantle Cell Lymphoma
  • +4 more
  • Chicago, Illinois
  • +4 more
Apr 30, 2021

Ann Arbor Stage III Grade 1 Follicular Lymphoma, Ann Arbor Stage III Grade 2 Follicular Lymphoma, Ann Arbor Stage III Indolent

Completed
Has Results
  • Ann Arbor Stage III Grade 1 Follicular Lymphoma
  • +9 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 28, 2021

Late Effects, Testicular Germ Cell Tumor Mixed, Non-Metastatic Breast Carcinoma Trial in Lyon (PASCA intervention)

Recruiting
  • Late Effects
  • +8 more
  • PASCA intervention
  • Lyon, France
    Centre Leon Berard
Mar 15, 2022

Tissue, Blood, and Body Fluid Sample Collection From Hematologic

Recruiting
  • Chronic Myeloproliferative Disorders
  • +7 more
  • biologic sample preservation procedure
  • cytology specimen collection procedure
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
Oct 14, 2021

Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma AJCC v8, Clinical Stage IB Cutaneous Melanoma

Recruiting
  • Clinical Stage I Cutaneous Melanoma AJCC v8
  • +33 more
  • Informational Intervention
  • +4 more
  • Los Angeles, California
  • +4 more
Dec 14, 2022

Collecting and Storing Blood Samples From Patients With Cancer

Withdrawn
  • Brain and Central Nervous System Tumors
  • +10 more
    • (no location specified)
    Sep 20, 2021

    Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

    Terminated
    Has Results
    • Accelerated Phase Chronic Myelogenous Leukemia
    • +110 more
    • Omaha, Nebraska
      University of Nebraska Medical Center
    Feb 6, 2019

    Ann Arbor Stage II Non-Hodgkin Lymphoma, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial

    Active, not recruiting
    Has Results
    • Ann Arbor Stage II Non-Hodgkin Lymphoma
    • +2 more
    • Mobile, Alabama
    • +189 more
    Jan 28, 2023

    Adult Burkitt Lymphoma, B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between DLBCL and Burkitt Lymphoma, DLBCL

    Active, not recruiting
    Has Results
    • Adult Burkitt Lymphoma
    • +4 more
    • Chicago, Illinois
    • +4 more
    Feb 17, 2022

    Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Diffuse Astrocytoma Trial in New York (other, drug,

    Completed
    Has Results
    • Adult Anaplastic Astrocytoma
    • +8 more
    • Laboratory Biomarker Analysis
    • +3 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jun 28, 2021

    Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

    Completed
    Has Results
    • Adult Nasal Type Extranodal NK/T-cell Lymphoma
    • +35 more
    • Akt inhibitor MK2206
    • laboratory biomarker analysis
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 14, 2020

    Lymphoma, Non-Hodgkin, Advanced Stage Diffuse Large B-Cell Non-Hodgkin's Lymphoma Trial in Vancouver (Cyclophosphamide,

    Active, not recruiting
    • Lymphoma, Non-Hodgkin
    • Advanced Stage Diffuse Large B-Cell Non-Hodgkin's Lymphoma
    • Vancouver, British Columbia, Canada
      BC Cancer Agency
    Jul 20, 2021

    Lymphomas Non-Hodgkin's B-Cell Trial in Ballarat, Box Hill, Heidelberg (Avelumab)

    Active, not recruiting
    • Lymphomas Non-Hodgkin's B-Cell
    • Ballarat, Victoria, Australia
    • +2 more
    Jan 30, 2023

    Cutaneous T-Cell Lymphoma/Mycosis Fungoides Trial in Gdansk (WP1220)

    Completed
    • Cutaneous T-Cell Lymphoma/Mycosis Fungoides
    • Gdansk, Poland
      Medical University of Gdansk
    Jan 8, 2021

    Composite Lymphoma, Grade 3b Follicular Lymphoma, Stage I DLBCL Trial in Seattle (drug, other, biological)

    Completed
    Has Results
    • Composite Lymphoma
    • +9 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Sep 22, 2020